Malignant mesothelioma (MM) is associated with asbestos exposure and the presence of SV40 viral sequences. Recently, we reported that SV40 infection of human mesothelial cells (HM) causes aberrant methylation of the tumor suppressor gene (TSG) RASSF1A. We investigated methylation of 12 genes by methylation-specific PCR in 63 MMs, six MM cell lines, and two foci of SV40-infected HM. Methylation percentages of the tested genes ranged from 3 to 65%. The frequencies of HPP1, RASSF1A, Cyclin D2, and RRAD methylation, and the value of the methylation index, were significantly higher in SV40 sequence-positive MMs than in SV40-negative MMs. Methylation of TMS1 and HIC-1 was associated with shortened survival. SV40-infected HM showed progressive aberrant methylation of seven genes (RASS-F1A, HPP1, DcR1, TMS1, CRBP1, HIC-1, and RRAD) during serial passage. Our results demonstrate a relationship between SV40 and methylation of multiple genes in MM, indicating that the virus plays a role in the pathogenesis of MM.
Malignant mesothelioma (MM) is a lethal neoplastic disease of mesothelial surfaces that usually presents at an advanced stage. MMs have been linked to asbestos exposure from industrial and other environmental sources. However, only about 5% of people heavily exposed to the asbestos develop MM, suggesting that additional factors are needed for tumor development (Rizzo et al., 2001; Powers and Carbone, 2002) . Our understanding of the pathogenesis of MM is complicated by the lack of consistent chromosomal breakpoints or mutations in common tumor suppressor genes (TSGs) such as p53 (Sandberg and Bridge, 2001 ). SV40 is a potent DNA tumorigenic tumor virus that preferentially causes mesothelioma in hamsters when injected intracardially or intrapleurally (Cicala et al., 1993) . SV40 is a unique carcinogen that simultaneously inactivates p53 and Rb, induces telomerase activity, and activates other oncogenes and growth factor secretion . Recently, SV40 has been specifically linked to MM development (Rizzo et al., 2001; Gazdar and Carbone, 2003) , and human normal mesothelial cells are uniquely susceptible to SV40 infection and transformation (Bocchetta et al., 2000) . However, relatively little is known about the molecular biology of MM.
Promoter methylation and the associated phenomenon of histone deacetylation are epigenetic changes in chromatin structure that do not alter the DNA sequence and can cause gene inactivation (Bird, 1986) . Aberrant promoter methylation can inactivate TSGs and can promote tumor development and/or progression including MM (Wong et al., 2002) . In our original methylation screen, we identified only one TSG (RASSF1A) methylated frequently in MMs and demonstrated a relationship between methylation and SV40 DNA sequences (Toyooka et al., 2001) . Further, SV40-induced transformation of normal mesothelial cells was associated with progressive methylation of RASSF1A during cell passage . As these observations were limited to a single gene, in order to confirm and extend these findings, we studied the methylation status of additional known or suspected TSGs. We correlated methylation with the presence of SV40 in infected human mesothelial cells (HM) and resected MMs.
Aberrant methylation of TSGs in MM cell lines and primary MMs
Six MM cell lines (NCI-H28, NCI-H226, NCI-H290, NCI-H513, NCI-H2052, and NCI-H2452) established by us (Pass et al., 1995; Phelps et al., 1996) were used for this study. Four primary HM cultures were established from normal or reactive mesothelial cells from effusions arising in cancer-free patients. SV40 infected HM were established and passaged as described previously (Bocchetta et al., 2000) . One of the authors (HIP) collected 63 resected primary MMs that were treated uniformly, after obtaining Institutional Review Board approval and signed consent. Histological records were available from 50 of the cases, of which 39 were of the epithelial type and 11 were sarcomatoid/mixed types. Extraction of genomic DNA and bisulfite treatment were performed as described previously (Toyooka et al., 2001) . To further study the methylation profile of MMs, we selected 11 genes frequently methylated in other tumor types. We compared our results with those of RASSF1A as determined previously . Aberrant methylation of the DRM/Gremlin, RRAD, NORE1A, RIZ1, DcR1, DcR2, CyclinD2, TMS1, HIC-1, CRBP1, and HPP1 genes was determined using gene-specific primers for the methylated and unmethylated forms of the promoter regions by the method of MSP (Toyooka et al., 2001) . The primer sequences are presented in Table 1 . Results were confirmed by repeating bisulfite treatment and MSP for all positive samples.
In the four primary mesothelial cell cultures, aberrant methylation of the 12 genes tested was completely absent, and all of the genes were expressed. Methylation frequencies of the genes in six MM cell lines varied from 33 to 83% (Table 2) . We also examined the relationship between mRNA expression and methylation of six genes that showed more than 30% frequencies in MMs, and we found complete concordance between expression of the genes in six MM cell lines (42 of 42, 100%, data not shown).
The methylation frequencies of the genes in MMs ranged from 3 to 65% (Table 2) , eight of which were methylated at frequencies greater than 20%. In all, 59 out of 63 tumors (94%) had methylation of one or more genes.
Previous studies have identified relatively few genes methylated at frequencies greater than 20% in MMs (Toyooka et al., 2001; Hirao et al., 2002; Wong et al., 2002) . In our initial study, only one (RASSF1A) of seven genes studied had a frequency of methylation greater than 20% (Toyooka et al., 2001) . In the present study, we found that eight of 12 genes studied (DcR1, DRM/ Gremlin, RRAD, DcR2, HPP1, Cyclin D2, RASSF1A, and HIC-1) had methylation frequencies higher than 20% in MMs. Thus, silencing of TSGs by epigenetic phenomena is frequent in MMs, and as observed in other tumors (Esteller et al., 2001 ) the spectrum of genes involved is characteristic of the tumor type.
DcR1 and DcR2 are antiapoptotic decoy receptors to which tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can bind. These two decoy receptors are known to be methylated in pediatric tumors (van Noesel et al., 2002) and other cancers (Shivapurkar et al., 2004b) . Methylation of Cyclin D2, a crucial cell cycleregulatory gene, has been described in many human cancers, including prostate and lung cancers (Padar et al., 2003; Virmani et al., 2003a) . The HPP1 gene is frequently methylated in hyperplastic polyps of the colon, and in colorectal , gastric , and lung cancers (author's unpublished data). HIC-1 (hypermethylated in cancer), a zinc-finger transcription factor gene, has a p53-binding site by which the gene is activated (Wales et al., 1995) , and methylation of the gene has been described in many human cancers (Rathi et al., 2002 (Rathi et al., , 2003 . NORE1A, a member of the RASSF1 gene family, is inactivated in a subset of human cancers by methylation (Hesson et al., 2003) . Cellular retinol-binding protein 1 (CRBP1), a carrier of the alcoholic form of vitamin A, plays an important role in the retinoid signaling pathway and is methylated in various human cancers (Esteller et al., 2002) . The retinoblastoma protein-interacting zincfinger gene RIZ1 is a member of a nuclear histone/ protein methyltransferase superfamily, and is methylated in human liver and breast cancers (Du et al., 2001) . DRM/Gremlin gene was first isolated as the human homolog of the rat drm gene (Topol et al., 1997; Hsu et al., 1998), and Topol et al. (2000) reported that the gene was downregulated in many types of human cancers. RRAD is a small GTPase that was initially cloned as a mRNA overexpressed in the skeletal muscle of some type II diabetics (Reynet and Kahn, 1993) . A Table 2 Frequency of methylation in MM cell lines and tumors, and its correlation of the SV40 Tag sequence recent study has shown that RRAD influenced the growth and the tumorigenicity of breast cancer cells (Tseng et al., 2001) . We examined the methylation of these two genes because they are downregulated in lung and breast cancers and downregulation is associated with aberrant methylation (Suzuki et al., manuscript in preparation). Methylation of both genes was higher than 50% in MMs, and RRAD methylation was significantly correlated with SV40.
SV40 tag sequences in samples
PCR was performed to amplify a 105 bp region as described previously (Shivapurkar et al., 1999; Toyooka et al., 2001 Toyooka et al., , 2002 
Correlation between patients' survival and methylation of MMs
Survival data were available for 50 patients with a median follow-up period of 14.5 months, and ranged from 2 to 68 months. Presence of SV40 Tag sequence, histologic subtypes, or MI (divided into two groups by median value) did not affect survival. However, patients with TMS1 (P ¼ 0.01) or HIC-1 (P ¼ 0.02) methylation, and patients with methylation of either gene (P ¼ 0.004), had significantly worse overall survival than patients without methylation by log-rank test (Figure 1 ), although neither gene was methylated at high frequencies. There was no correlation between methylation of each gene and age, gender, pathologic types, or stage (data not shown). Figure 1 Overall survival curves of MMs (n ¼ 50). The effect of methylation on patient survival was estimated by the KaplanMeier method, and differences between two groups were compared using the log-rank test. M þ , methylated; MÀ, unmethylated. Overall survival curve according to TMS1 methylation status (a), HIC-1 methylation status (b), or either TMS1 or HIC-1 methylation status (c) Although its exact role in pathogenesis of cancer is unknown, loss of HIC-1 expression or HIC-1 promoter methylation correlates with poor survival in medulloblastoma, lung, and breast cancers (Hayashi et al., 2001; Nicoll et al., 2001; Rood et al., 2002) . TMS1 encodes a novel caspase recruitment domain (CARD) protein and induces apoptosis in human cells. TMS1 is aberrantly methylated and silenced in breast and lung cancer cells (Conway et al., 2000; Virmani et al., 2003b) . Recent studies have identified prognostic molecular markers in MMs (Baas, 2003; Edwards et al., 2003; Gordon et al., 2003) . We propose that HIC-1 and TMS1 methylation are novel markers to predict survival of MM patients.
Progressive aberrant methylation of the TSGs tested in SV40-infected HM
We examined the methylation status of the genes in two independent foci (F1 and F4) of HM infected with SV40 during serial passage and transformation ( Figure 2 and Table 3 ). As mentioned previously, normal and reactive mesothelial cells lacked methylation of all genes. Methylation of six (focus 4) or seven (focus 1) genes was noted after SV40 infection. Except for DcR1 methylation in focus 1, methylation was absent in early passages (p6-p12), but was noted in later passages (p51-p60).
As a representative example, we performed sequencing of the RRAD gene of cloned bisulfite treated genomic DNA obtained from multiple passages of foci F1 and F4. As demonstrated in Figure 2 , there was no or minimal methylation in early passage and progressively all clones demonstrated increased methylation during later passages.
The role of SV40 in human tumorigenesis has been controversial, although several recent consensus meetings and reviews have concluded that the evidence that SV40 sequences are present in about 50% of human mesotheliomas is strong (Rizzo et al., 2001; Gazdar et al., 2002; Powers and Carbone, 2002) . However, it is important to distinguish between association (i.e. the presence of SV40 virus sequences) in a tumor and its role in tumor causality . HM have been found to be unusually susceptible to SV40-mediated transformation (Bocchetta et al., 2000) . Moreover, SV40 is a strong human carcinogen and SV40 preferentially causes MM when injected systemically in hamsters (Cicala et al., 1993) . Our previous study demonstrated that methylation of the RASSF1A gene correlated with and 5 0 -CCTCCCCCAACCCCCAAAT-3 0 (reverse). These primers were designed to exclude binding to any CpG dinucleotide to ensure amplification of both methylated and unmethylated sequences. PCR products were cloned into plasmid vectors using the Topo TA cloning kit (Invitrogen), following the manufacturer's instructions. (Toyooka et al., 2001) and that transformation of mesothelial cells by SV40 resulted in progressive methylation of the gene . While we regarded this as evidence that SV40 contributes to the pathogenesis of MM, the study was weakened by being limited to a single gene. In the present study, however, we demonstrate a significant correlation between the presence of SV40 and methylation of three more genes (HPP1, Cyclin D2, and RRAD) and a borderline correlation with one additional gene (TMS1). Moreover, SV40-infected HM demonstrated passagedependent methylation of seven of the 12 genes tested, including four of the five genes associated with SV40. Clonal analyses of one of the genes, RRAD, confirmed progressive methylation with passage after SV40 infection. These data provide powerful evidence that SV40 infection of HM induces methylation of several TSGs. SV40 infection of mammalian cells induces expression of the methyltransferase enzymes DNMT1 or DNMT3b and results in global genomic DNA methylation and/or TSG silencing (Slack et al., 1999; Soejima et al., 2003) .
We have detected the presence of SV40 sequences in lymphomas (Shivapurkar et al., , 2004a and leukemias (Shivapurkar et al., 2004a) . In hematological malignancies, the presence of SV40 sequences is tightly correlated with the methylation and silencing of multiple TSGs (Shivapurkar et al., 2004a) . Methylation of host cell genes is not unique to SV40 and occurs with other oncogenic viruses. Epstein-Barr virus induces methylation of multiple genes in gastric carcinoma (Kang et al., 2002) , and hepatitis B and C viruses in hepatocellular carcinoma (Yang et al., 2003) . Although SV40 appears capable of causing MM, asbestos remains the carcinogen most frequently associated with this cancer. A synergistic effect among SV40 and asbestosis is suspected (Powers and Carbone, 2002) . In his model, SV40 inactivates TSGs through promoter methylation and inhibitory binding of p53 and Rb, while asbestos stimulates the ERK pathway to promote cell mitosis (Zanella et al., 1996) .
From our and other published findings , it appears that SV40 may induce both genetic and epigenetic changes in infected cells, forming the basis for a transformation mechanism more complex than simple inactivation of the p53 and Rb gene products by Tag antigen . Our findings provide evidence that the close relationship between the presence of SV40 sequences in a subset of mesotheliomas and aberrant methylation of TSGs contributes to the malignant phenotype. SV40-induced promoter methylation is a novel mechanism in the pathogenesis MM and other human tumors.
Abbreviations MM, malignant pleural mesothelioma; HM, human mesothelial cells; SV40, simian virus 40; TSG, tumor suppressor gene. 
